Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Free Cash Flow: 2010-2024

Historic Free Cash Flow for Kura Oncology (KURA) over the last 14 years, with Dec 2024 value amounting to $133.8 million.

  • Kura Oncology's Free Cash Flow fell 91.51% to -$83.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.1 million, marking a year-over-year change of. This contributed to the annual value of $133.8 million for FY2024, which is 207.08% up from last year.
  • Kura Oncology's Free Cash Flow amounted to $133.8 million in FY2024, which was up 207.08% from -$125.0 million recorded in FY2023.
  • Kura Oncology's 5-year Free Cash Flow high stood at $133.8 million for FY2024, and its period low was -$125.0 million during FY2023.
  • Its 3-year average for Free Cash Flow is -$33.9 million, with a median of -$110.7 million in 2022.
  • In the last 5 years, Kura Oncology's Free Cash Flow crashed by 46.80% in 2021 and then spiked by 207.08% in 2024.
  • Kura Oncology's Free Cash Flow (Yearly) stood at -$72.0 million in 2020, then plummeted by 46.80% to -$105.7 million in 2021, then fell by 4.72% to -$110.7 million in 2022, then dropped by 12.92% to -$125.0 million in 2023, then surged by 207.08% to $133.8 million in 2024.